Boryung Corporation (KRX:003850)
South Korea · Delayed Price · Currency is KRW 9,420.00
-40.00 (-0.42%)
Last updated: May 19, 2026, 11:29 AM KST
Boryung Company Description
Boryung Corporation produces and sells pharmaceutical products in South Korea.
The company offers cardiovascular products, anticancer products, gastrointestinal products, and API's.
It also exports its products to approximately 50 countries on 6 continents, including Japan, China, the Southeast Asia, the Middle East, Europe, South America, and Africa.
The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022.
Boryung Corporation was founded in 1957 and is based in Seoul, South Korea.
Boryung Corporation
| Country | South Korea |
| Founded | 1957 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Jung-Gyun Kim |
Contact Details
Address: Boryeong Building Seoul South Korea | |
| Phone | 82 2 708 8000 |
Stock Details
| Ticker Symbol | 003850 |
| Exchange | Korea Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7003850005 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Daniel Chang | Chief Executive Officer of Pharma Biz |
| Jung-Gyun Kim | Chairman and Chief Executive Officer |
| Sung Jin Kim | Chief Strategy Officer and Director |